FRIDAY, April 22, 2022 (HealthDay News) — In a new guideline from the American College of Gastroenterology, published in the April issue of American Journal of Gastroenterologyscreening methods have been expanded and guidelines have been updated on intervals and techniques for monitoring patients with Barrett’s esophagus (BE).
Nicholas J. Shaheen, MD, MPH, of the University of North Carolina at Chapel Hill, and colleagues have developed updated guidelines for the diagnosis and management of EB.
The authors recommend that dysplasia of any grade detected on BE biopsies be confirmed by a second pathologist who has expertise in gastrointestinal pathology. Acceptable screening modalities for EB now include non-endoscopic methods. White light endoscopy and chromoendoscopy are recommended for patients undergoing endoscopic surveillance for EB. The length of the BE segment should be considered when assigning monitoring intervals, with longer intervals reserved for individuals with BE segments
“This revised guideline synthesizes current best practice in BE management, with several key changes since the last iteration that reflect the evolution of our knowledge base,” the authors write.
Several authors disclosed financial ties to the biopharmaceutical industry.